growth pop seq
thesi updat expect gener bore print
tonight given bevi releas includ pre-a initi
guid modest controversi develop post call
given soft revenu guid confirm novaseq
shortfal box light fy despit massiv
term guid think like conserv
contempl normal instrument revenu post
elev period stock order sequenc
consum row mute result consum array
tough comp sequenc servic gel may
play tough gaug view feel unlik also
impli notabl growth acceler balanc year
given signific ramp popul sequenc project scari
sensibl us given known larg project franc
us bangladesh singapor dubai name
thu concern cadenc point
sequenc consum growth fy key metric
term judg end market health respect
disappoint novaseq placement shortfal think
demand driven like function time custom
readi accept deliveri given underli util
remain healthi box placement overal expect grow
sign market troubl whatsoev
earli adopt curv make sens
 volatil materi deceler key
mind popseq major upsid variabl like
array given conserv approach dtc growth furthermor
expect new product cadenc remain healthi given
level announc cater potenti custom vs
investor thesi chang market potenti
forecast like bias upward also remain construct
pend acquisit could provid nice jolt
number reiter overweight rate
recommend buy weak
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
model/pt updat estim move higher due
lower tax construct view potenti revenu
dilut estim tweak lower given
conserv view consum array sequenc servic well
slightli slower synergi ramp final estim
remain unchang term pt move slightli lower given
slight tweak forecast normal perpetu
growth rate tradit tool impli price-to-earnings line
level last year averag adjust cash
hand helix dilut
weight yr rev
sequenc rev mid-teen instrument hsd
nova flat slightli consum
expect popseq growth
gm glightli mix
opex slightli revenu vs
tax vs due tax benefit helix
revenu qoq
pull-forward
sequenc system mm qoq season
sequenc consumal flat slightli qoq
gm slightli qoq
opex rev flat qoq
tax meaning lower vs due benefit
share count similar
china impact tariff-rel stock pull-fwd
would adjust
new cust account placement
surpris upsid
clinic sequenc becom larger part stori
launch sever product address notabl
pan-canc assay tmb microsatellit instabl
receiv breakthrough design fda
debat point cc
miss placement guid vs guid
due delay custom readi receiv instrument
comfort custom demand maintain mult-yr
margin meaning due pressur mix
roll-off gel slow ramp popseq project
lower price flow cell launch sprime flow cell
sequenc guid bit light due tariff pull-forward
consum instrument
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
laboratori corp america
articl articl
time dissemin januari
analyst luke sergott ross muken primarili respons prepar research report attest follow view
opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
